nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—ABCB1—peripheral nervous system neoplasm	0.361	1	CbGaD
Trimipramine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0364	0.132	CbGbCtD
Trimipramine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0364	0.132	CbGbCtD
Trimipramine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0349	0.126	CbGbCtD
Trimipramine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0252	0.0912	CbGbCtD
Trimipramine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0218	0.0788	CbGbCtD
Trimipramine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0203	0.0733	CbGbCtD
Trimipramine—HTR1D—meninx—peripheral nervous system neoplasm	0.016	0.136	CbGeAlD
Trimipramine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0155	0.0562	CbGbCtD
Trimipramine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0149	0.054	CbGbCtD
Trimipramine—HTR1D—dura mater—peripheral nervous system neoplasm	0.0147	0.125	CbGeAlD
Trimipramine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0145	0.0524	CbGbCtD
Trimipramine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0142	0.0515	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00972	0.0351	CbGbCtD
Trimipramine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00932	0.0336	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00916	0.0331	CbGbCtD
Trimipramine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00859	0.0729	CbGeAlD
Trimipramine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00854	0.0308	CbGbCtD
Trimipramine—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.00728	0.0618	CbGeAlD
Trimipramine—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00632	0.0536	CbGeAlD
Trimipramine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00582	0.021	CbGbCtD
Trimipramine—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00555	0.047	CbGeAlD
Trimipramine—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.0045	0.0382	CbGeAlD
Trimipramine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00314	0.0266	CbGeAlD
Trimipramine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00294	0.0249	CbGeAlD
Trimipramine—HTR3A—nerve—peripheral nervous system neoplasm	0.00284	0.0241	CbGeAlD
Trimipramine—HTR3A—ganglion—peripheral nervous system neoplasm	0.00281	0.0238	CbGeAlD
Trimipramine—SLC6A3—nerve—peripheral nervous system neoplasm	0.00236	0.0201	CbGeAlD
Trimipramine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00234	0.0198	CbGeAlD
Trimipramine—HTR1D—ganglion—peripheral nervous system neoplasm	0.00228	0.0193	CbGeAlD
Trimipramine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00226	0.0192	CbGeAlD
Trimipramine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00224	0.019	CbGeAlD
Trimipramine—HTR2A—pons—peripheral nervous system neoplasm	0.00221	0.0188	CbGeAlD
Trimipramine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00214	0.0182	CbGeAlD
Trimipramine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00191	0.0162	CbGeAlD
Trimipramine—HTR1A—ganglion—peripheral nervous system neoplasm	0.0019	0.0161	CbGeAlD
Trimipramine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00188	0.016	CbGeAlD
Trimipramine—DRD2—nerve—peripheral nervous system neoplasm	0.00174	0.0148	CbGeAlD
Trimipramine—DRD2—ganglion—peripheral nervous system neoplasm	0.00172	0.0146	CbGeAlD
Trimipramine—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.00138	0.0117	CbGeAlD
Trimipramine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00131	0.276	CrCbGaD
Trimipramine—HTR3A—brainstem—peripheral nervous system neoplasm	0.00122	0.0104	CbGeAlD
Trimipramine—HTR2A—nerve—peripheral nervous system neoplasm	0.00115	0.00973	CbGeAlD
Trimipramine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00113	0.00961	CbGeAlD
Trimipramine—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00112	0.0095	CbGeAlD
Trimipramine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.00102	0.00861	CbGeAlD
Trimipramine—HTR1D—brainstem—peripheral nervous system neoplasm	0.000991	0.00841	CbGeAlD
Trimipramine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000981	0.00833	CbGeAlD
Trimipramine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.00093	0.00789	CbGeAlD
Trimipramine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000826	0.00701	CbGeAlD
Trimipramine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000819	0.00695	CbGeAlD
Trimipramine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.000811	0.17	CrCbGaD
Trimipramine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000761	0.00646	CbGeAlD
Trimipramine—DRD2—brainstem—peripheral nervous system neoplasm	0.000746	0.00633	CbGeAlD
Trimipramine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.000743	0.156	CrCbGaD
Trimipramine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000666	0.00565	CbGeAlD
Trimipramine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000654	0.00555	CbGeAlD
Trimipramine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.0005	0.00425	CbGeAlD
Trimipramine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000492	0.00418	CbGeAlD
Trimipramine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000448	0.0038	CbGeAlD
Trimipramine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000407	0.00345	CbGeAlD
Trimipramine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000375	0.00318	CbGeAlD
Trimipramine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000368	0.00312	CbGeAlD
Trimipramine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.00184	CcSEcCtD
Trimipramine—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000364	0.00183	CcSEcCtD
Trimipramine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000364	0.00309	CbGeAlD
Trimipramine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00036	0.00181	CcSEcCtD
Trimipramine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.0018	CcSEcCtD
Trimipramine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000358	0.0018	CcSEcCtD
Trimipramine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000357	0.0018	CcSEcCtD
Trimipramine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000356	0.00179	CcSEcCtD
Trimipramine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000355	0.00178	CcSEcCtD
Trimipramine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000353	0.00177	CcSEcCtD
Trimipramine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00035	0.00176	CcSEcCtD
Trimipramine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.00175	CcSEcCtD
Trimipramine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000347	0.00174	CcSEcCtD
Trimipramine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000347	0.00174	CcSEcCtD
Trimipramine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000346	0.00174	CcSEcCtD
Trimipramine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000345	0.00173	CcSEcCtD
Trimipramine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000345	0.00173	CcSEcCtD
Trimipramine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000343	0.00173	CcSEcCtD
Trimipramine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000343	0.00172	CcSEcCtD
Trimipramine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000342	0.00172	CcSEcCtD
Trimipramine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00172	CcSEcCtD
Trimipramine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000342	0.00172	CcSEcCtD
Trimipramine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000342	0.00172	CcSEcCtD
Trimipramine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000341	0.00171	CcSEcCtD
Trimipramine—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000338	0.0017	CcSEcCtD
Trimipramine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000337	0.0017	CcSEcCtD
Trimipramine—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.0017	CcSEcCtD
Trimipramine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000336	0.00169	CcSEcCtD
Trimipramine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000333	0.00168	CcSEcCtD
Trimipramine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00167	CcSEcCtD
Trimipramine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000331	0.00167	CcSEcCtD
Trimipramine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00167	CcSEcCtD
Trimipramine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000331	0.00166	CcSEcCtD
Trimipramine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000331	0.00166	CcSEcCtD
Trimipramine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00033	0.00166	CcSEcCtD
Trimipramine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00165	CcSEcCtD
Trimipramine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000326	0.00164	CcSEcCtD
Trimipramine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00164	CcSEcCtD
Trimipramine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000326	0.00164	CcSEcCtD
Trimipramine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000325	0.00163	CcSEcCtD
Trimipramine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000324	0.00163	CcSEcCtD
Trimipramine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000322	0.00162	CcSEcCtD
Trimipramine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000322	0.00162	CcSEcCtD
Trimipramine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00162	CcSEcCtD
Trimipramine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00032	0.00161	CcSEcCtD
Trimipramine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00032	0.00161	CcSEcCtD
Trimipramine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000319	0.0016	CcSEcCtD
Trimipramine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.0016	CcSEcCtD
Trimipramine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000317	0.00159	CcSEcCtD
Trimipramine—Epinastine—ABCB1—peripheral nervous system neoplasm	0.000317	0.0665	CrCbGaD
Trimipramine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000316	0.00159	CcSEcCtD
Trimipramine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000316	0.00159	CcSEcCtD
Trimipramine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.00157	CcSEcCtD
Trimipramine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00157	CcSEcCtD
Trimipramine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.00157	CcSEcCtD
Trimipramine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.00157	CcSEcCtD
Trimipramine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000312	0.00157	CcSEcCtD
Trimipramine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00031	0.00156	CcSEcCtD
Trimipramine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00155	CcSEcCtD
Trimipramine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000307	0.00154	CcSEcCtD
Trimipramine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000307	0.00154	CcSEcCtD
Trimipramine—Rash—Topotecan—peripheral nervous system neoplasm	0.000307	0.00154	CcSEcCtD
Trimipramine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000307	0.00154	CcSEcCtD
Trimipramine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000307	0.00154	CcSEcCtD
Trimipramine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00154	CcSEcCtD
Trimipramine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000306	0.00154	CcSEcCtD
Trimipramine—Headache—Topotecan—peripheral nervous system neoplasm	0.000305	0.00153	CcSEcCtD
Trimipramine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000305	0.00153	CcSEcCtD
Trimipramine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000305	0.00153	CcSEcCtD
Trimipramine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000305	0.00153	CcSEcCtD
Trimipramine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000304	0.00153	CcSEcCtD
Trimipramine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000304	0.00153	CcSEcCtD
Trimipramine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000304	0.00153	CcSEcCtD
Trimipramine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000304	0.00153	CcSEcCtD
Trimipramine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000303	0.00152	CcSEcCtD
Trimipramine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000303	0.00152	CcSEcCtD
Trimipramine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000303	0.00152	CcSEcCtD
Trimipramine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000302	0.00152	CcSEcCtD
Trimipramine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.00152	CcSEcCtD
Trimipramine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000302	0.00152	CcSEcCtD
Trimipramine—Rash—Melphalan—peripheral nervous system neoplasm	0.000301	0.00151	CcSEcCtD
Trimipramine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0003	0.00151	CcSEcCtD
Trimipramine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000297	0.0015	CcSEcCtD
Trimipramine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000295	0.00148	CcSEcCtD
Trimipramine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.000293	0.0616	CrCbGaD
Trimipramine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000292	0.00147	CcSEcCtD
Trimipramine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00146	CcSEcCtD
Trimipramine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00146	CcSEcCtD
Trimipramine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00146	CcSEcCtD
Trimipramine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000289	0.00145	CcSEcCtD
Trimipramine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000288	0.00145	CcSEcCtD
Trimipramine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000287	0.00144	CcSEcCtD
Trimipramine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000287	0.00144	CcSEcCtD
Trimipramine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000285	0.00242	CbGeAlD
Trimipramine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00143	CcSEcCtD
Trimipramine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000283	0.00142	CcSEcCtD
Trimipramine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000283	0.00142	CcSEcCtD
Trimipramine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00028	0.00141	CcSEcCtD
Trimipramine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00028	0.00141	CcSEcCtD
Trimipramine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000279	0.0014	CcSEcCtD
Trimipramine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000279	0.0014	CcSEcCtD
Trimipramine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000279	0.0014	CcSEcCtD
Trimipramine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000279	0.0014	CcSEcCtD
Trimipramine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000273	0.00137	CcSEcCtD
Trimipramine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00136	CcSEcCtD
Trimipramine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00027	0.00136	CcSEcCtD
Trimipramine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00135	CcSEcCtD
Trimipramine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000267	0.00134	CcSEcCtD
Trimipramine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00132	CcSEcCtD
Trimipramine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00131	CcSEcCtD
Trimipramine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.0013	CcSEcCtD
Trimipramine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.0013	CcSEcCtD
Trimipramine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000257	0.00129	CcSEcCtD
Trimipramine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000257	0.00129	CcSEcCtD
Trimipramine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000256	0.00129	CcSEcCtD
Trimipramine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000254	0.00128	CcSEcCtD
Trimipramine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000253	0.00127	CcSEcCtD
Trimipramine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00126	CcSEcCtD
Trimipramine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000251	0.00126	CcSEcCtD
Trimipramine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00126	CcSEcCtD
Trimipramine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000249	0.00125	CcSEcCtD
Trimipramine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000249	0.00125	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00124	CcSEcCtD
Trimipramine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000247	0.00124	CcSEcCtD
Trimipramine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000246	0.00124	CcSEcCtD
Trimipramine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00124	CcSEcCtD
Trimipramine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00123	CcSEcCtD
Trimipramine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00123	CcSEcCtD
Trimipramine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000244	0.00123	CcSEcCtD
Trimipramine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000243	0.00206	CbGeAlD
Trimipramine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00122	CcSEcCtD
Trimipramine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000241	0.00121	CcSEcCtD
Trimipramine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00121	CcSEcCtD
Trimipramine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00119	CcSEcCtD
Trimipramine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000236	0.00118	CcSEcCtD
Trimipramine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000235	0.00118	CcSEcCtD
Trimipramine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00118	CcSEcCtD
Trimipramine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000233	0.00117	CcSEcCtD
Trimipramine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.00117	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00117	CcSEcCtD
Trimipramine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000231	0.00116	CcSEcCtD
Trimipramine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000231	0.00116	CcSEcCtD
Trimipramine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00115	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00115	CcSEcCtD
Trimipramine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000227	0.00114	CcSEcCtD
Trimipramine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00114	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00114	CcSEcCtD
Trimipramine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000226	0.00114	CcSEcCtD
Trimipramine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000226	0.00114	CcSEcCtD
Trimipramine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00113	CcSEcCtD
Trimipramine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000224	0.00113	CcSEcCtD
Trimipramine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00113	CcSEcCtD
Trimipramine—Rash—Vincristine—peripheral nervous system neoplasm	0.000223	0.00112	CcSEcCtD
Trimipramine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000222	0.00112	CcSEcCtD
Trimipramine—Headache—Vincristine—peripheral nervous system neoplasm	0.000221	0.00111	CcSEcCtD
Trimipramine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000221	0.00188	CbGeAlD
Trimipramine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00109	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00109	CcSEcCtD
Trimipramine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000214	0.00107	CcSEcCtD
Trimipramine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00106	CcSEcCtD
Trimipramine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00021	0.00105	CcSEcCtD
Trimipramine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00105	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00104	CcSEcCtD
Trimipramine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000205	0.00103	CcSEcCtD
Trimipramine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000202	0.00102	CcSEcCtD
Trimipramine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00101	CcSEcCtD
Trimipramine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.001	CcSEcCtD
Trimipramine—Carbamazepine—ABCB1—peripheral nervous system neoplasm	0.000199	0.0418	CrCbGaD
Trimipramine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000997	CcSEcCtD
Trimipramine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000989	CcSEcCtD
Trimipramine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000988	CcSEcCtD
Trimipramine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000196	0.000983	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000978	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000974	CcSEcCtD
Trimipramine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000967	CcSEcCtD
Trimipramine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000189	0.00095	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000937	CcSEcCtD
Trimipramine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000932	CcSEcCtD
Trimipramine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00093	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000927	CcSEcCtD
Trimipramine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000916	CcSEcCtD
Trimipramine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000182	0.000914	CcSEcCtD
Trimipramine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000907	CcSEcCtD
Trimipramine—Rash—Etoposide—peripheral nervous system neoplasm	0.00018	0.000906	CcSEcCtD
Trimipramine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00018	0.000905	CcSEcCtD
Trimipramine—Headache—Etoposide—peripheral nervous system neoplasm	0.000179	0.0009	CcSEcCtD
Trimipramine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000894	CcSEcCtD
Trimipramine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00089	CcSEcCtD
Trimipramine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000872	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000861	CcSEcCtD
Trimipramine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000855	CcSEcCtD
Trimipramine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00017	0.000854	CcSEcCtD
Trimipramine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000852	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000847	CcSEcCtD
Trimipramine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000168	0.0352	CrCbGaD
Trimipramine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000839	CcSEcCtD
Trimipramine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000837	CcSEcCtD
Trimipramine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00083	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000824	CcSEcCtD
Trimipramine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000822	CcSEcCtD
Trimipramine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000812	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000807	CcSEcCtD
Trimipramine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000806	CcSEcCtD
Trimipramine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000159	0.00135	CbGeAlD
Trimipramine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000791	CcSEcCtD
Trimipramine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000789	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000788	CcSEcCtD
Trimipramine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000786	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000775	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000768	CcSEcCtD
Trimipramine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000768	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00076	CcSEcCtD
Trimipramine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000753	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000752	CcSEcCtD
Trimipramine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000148	0.0312	CrCbGaD
Trimipramine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000745	CcSEcCtD
Trimipramine—Doxepin—ABCB1—peripheral nervous system neoplasm	0.000147	0.0309	CrCbGaD
Trimipramine—Methadone—ABCB1—peripheral nervous system neoplasm	0.000146	0.0307	CrCbGaD
Trimipramine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00073	CcSEcCtD
Trimipramine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000729	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000727	CcSEcCtD
Trimipramine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000723	CcSEcCtD
Trimipramine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000716	CcSEcCtD
Trimipramine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00071	CcSEcCtD
Trimipramine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000709	CcSEcCtD
Trimipramine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000139	0.0007	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000696	CcSEcCtD
Trimipramine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000695	CcSEcCtD
Trimipramine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000689	CcSEcCtD
Trimipramine—Desipramine—ABCB1—peripheral nervous system neoplasm	0.000135	0.0283	CrCbGaD
Trimipramine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000674	CcSEcCtD
Trimipramine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000669	CcSEcCtD
Trimipramine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000664	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000663	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000656	CcSEcCtD
Trimipramine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000648	CcSEcCtD
Trimipramine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000643	CcSEcCtD
Trimipramine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00064	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000637	CcSEcCtD
Trimipramine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000637	CcSEcCtD
Trimipramine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000637	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000614	CcSEcCtD
Trimipramine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000592	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000589	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000589	CcSEcCtD
Trimipramine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000578	CcSEcCtD
Trimipramine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.000115	0.0241	CrCbGaD
Trimipramine—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000114	0.024	CrCbGaD
Trimipramine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.000114	0.0239	CrCbGaD
Trimipramine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00057	CcSEcCtD
Trimipramine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000551	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000535	CcSEcCtD
Trimipramine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000533	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000527	CcSEcCtD
Trimipramine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000512	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00051	CcSEcCtD
Trimipramine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000508	CcSEcCtD
Trimipramine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000507	CcSEcCtD
Trimipramine—Headache—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000505	CcSEcCtD
Trimipramine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000493	CcSEcCtD
Trimipramine—Nausea—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000478	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.43e-05	0.000474	CcSEcCtD
Trimipramine—Rash—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.00047	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.00047	CcSEcCtD
Trimipramine—Headache—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000467	CcSEcCtD
Trimipramine—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000443	CcSEcCtD
Trimipramine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.99e-05	0.000497	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.99e-05	0.000496	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.99e-05	0.000495	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.97e-05	0.000491	CbGpPWpGaD
Trimipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.97e-05	0.00049	CbGpPWpGaD
Trimipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.97e-05	0.000489	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.96e-05	0.000488	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.96e-05	0.000487	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.96e-05	0.000487	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.95e-05	0.000485	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.94e-05	0.000483	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.93e-05	0.000481	CbGpPWpGaD
Trimipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.93e-05	0.00048	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.92e-05	0.000478	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.91e-05	0.000474	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.9e-05	0.000472	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.89e-05	0.00047	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.87e-05	0.000465	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.87e-05	0.000464	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.86e-05	0.000464	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.86e-05	0.000463	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	1.85e-05	0.00046	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.83e-05	0.000457	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.83e-05	0.000455	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.82e-05	0.000453	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.8e-05	0.000448	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.78e-05	0.000444	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.77e-05	0.000441	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.77e-05	0.00044	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.73e-05	0.000432	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.71e-05	0.000426	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.71e-05	0.000424	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.7e-05	0.000422	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.7e-05	0.000422	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	1.63e-05	0.000405	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.62e-05	0.000404	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	1.56e-05	0.000389	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.55e-05	0.000387	CbGpPWpGaD
Trimipramine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.55e-05	0.000385	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.51e-05	0.000376	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.5e-05	0.000373	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.5e-05	0.000373	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.49e-05	0.000372	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.49e-05	0.000371	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.47e-05	0.000367	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.47e-05	0.000366	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	1.47e-05	0.000366	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.46e-05	0.000363	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.45e-05	0.000361	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.44e-05	0.000359	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.44e-05	0.000358	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.43e-05	0.000356	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.42e-05	0.000355	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.39e-05	0.000346	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.39e-05	0.000346	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.38e-05	0.000344	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.34e-05	0.000334	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.32e-05	0.000329	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.32e-05	0.000329	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000328	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	1.31e-05	0.000326	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.3e-05	0.000324	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.3e-05	0.000323	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.29e-05	0.000322	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.28e-05	0.000319	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.28e-05	0.000318	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.28e-05	0.000317	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.27e-05	0.000316	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000316	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.26e-05	0.000314	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.26e-05	0.000313	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.25e-05	0.00031	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	1.25e-05	0.00031	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.24e-05	0.000308	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.23e-05	0.000307	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.22e-05	0.000304	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.21e-05	0.000302	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.21e-05	0.000301	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-05	0.0003	CbGpPWpGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000299	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.2e-05	0.000299	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.2e-05	0.000299	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.2e-05	0.000298	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.2e-05	0.000298	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.19e-05	0.000297	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	1.19e-05	0.000297	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.19e-05	0.000296	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.18e-05	0.000294	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.18e-05	0.000293	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.18e-05	0.000293	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.15e-05	0.000285	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000279	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.11e-05	0.000275	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.1e-05	0.000274	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.1e-05	0.000274	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.09e-05	0.000272	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.08e-05	0.000269	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000269	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.000263	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.05e-05	0.000262	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.04e-05	0.000259	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.03e-05	0.000256	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000253	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	0.000253	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.01e-05	0.000251	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1e-05	0.00025	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.71e-06	0.000242	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.62e-06	0.00024	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	9.57e-06	0.000238	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	9.49e-06	0.000236	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	9.45e-06	0.000235	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.39e-06	0.000234	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.34e-06	0.000233	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.18e-06	0.000229	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	9.04e-06	0.000225	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.02e-06	0.000225	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.97e-06	0.000223	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.86e-06	0.000221	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.85e-06	0.00022	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.82e-06	0.000219	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.6e-06	0.000214	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.59e-06	0.000214	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.52e-06	0.000212	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	8.49e-06	0.000211	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.44e-06	0.00021	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	8.33e-06	0.000207	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.29e-06	0.000206	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	7.98e-06	0.000199	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.92e-06	0.000197	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.87e-06	0.000196	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.81e-06	0.000194	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	7.81e-06	0.000194	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.79e-06	0.000194	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.78e-06	0.000194	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.78e-06	0.000194	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	7.74e-06	0.000193	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.67e-06	0.000191	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.66e-06	0.000191	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.64e-06	0.00019	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.63e-06	0.00019	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	7.6e-06	0.000189	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.5e-06	0.000187	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.26e-06	0.000181	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.14e-06	0.000178	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.09e-06	0.000176	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7e-06	0.000174	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.97e-06	0.000173	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.97e-06	0.000173	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.84e-06	0.00017	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.67e-06	0.000166	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.65e-06	0.000166	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.65e-06	0.000166	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.65e-06	0.000165	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.6e-06	0.000164	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.59e-06	0.000164	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.57e-06	0.000163	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.42e-06	0.00016	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.38e-06	0.000159	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.36e-06	0.000158	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.35e-06	0.000158	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.32e-06	0.000157	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.28e-06	0.000156	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.26e-06	0.000156	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.15e-06	0.000153	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.11e-06	0.000152	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.05e-06	0.000151	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.05e-06	0.000151	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.04e-06	0.00015	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.04e-06	0.00015	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.93e-06	0.000147	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.83e-06	0.000145	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.8e-06	0.000144	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.79e-06	0.000144	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.7e-06	0.000142	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.69e-06	0.000142	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.63e-06	0.00014	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.58e-06	0.000139	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.58e-06	0.000139	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.55e-06	0.000138	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.54e-06	0.000138	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.53e-06	0.000138	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.52e-06	0.000137	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.51e-06	0.000137	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.49e-06	0.000137	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.48e-06	0.000136	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.47e-06	0.000136	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.43e-06	0.000135	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.38e-06	0.000134	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.33e-06	0.000133	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.3e-06	0.000132	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.23e-06	0.00013	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.19e-06	0.000129	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.14e-06	0.000128	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.12e-06	0.000127	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.11e-06	0.000127	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.07e-06	0.000126	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.04e-06	0.000126	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.03e-06	0.000125	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.02e-06	0.000125	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.01e-06	0.000125	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5e-06	0.000124	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.96e-06	0.000124	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.94e-06	0.000123	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.93e-06	0.000123	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.73e-06	0.000118	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.68e-06	0.000116	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.61e-06	0.000115	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.6e-06	0.000115	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.59e-06	0.000114	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.58e-06	0.000114	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.51e-06	0.000112	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.36e-06	0.000108	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.29e-06	0.000107	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.28e-06	0.000107	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.22e-06	0.000105	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.2e-06	0.000105	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.19e-06	0.000104	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.08e-06	0.000101	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.06e-06	0.000101	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.04e-06	0.000101	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.9e-06	9.71e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.9e-06	9.7e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.88e-06	9.66e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.88e-06	9.65e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.71e-06	9.24e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.58e-06	8.91e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.57e-06	8.88e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.52e-06	8.77e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.51e-06	8.75e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.45e-06	8.58e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.44e-06	8.57e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.42e-06	8.52e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.42e-06	8.52e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.37e-06	8.38e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.36e-06	8.37e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.3e-06	8.21e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.28e-06	8.16e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	3.24e-06	8.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.2e-06	7.98e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.06e-06	7.63e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.02e-06	7.52e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.97e-06	7.4e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.97e-06	7.39e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.91e-06	7.25e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.71e-06	6.73e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.29e-06	5.71e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.24e-06	5.57e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.11e-06	5.25e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.09e-06	5.2e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.38e-06	3.43e-05	CbGpPWpGaD
